WCN26-3792 Mechanistic Kidney Effects of Semaglutide by Baseline SGLT2i Use in Type 2 Diabetes: A Post-hoc Analysis of the REMODEL Trial
David Z. I. Cherney, Radica Alicic, Milenta Chacko, Lynette Driscoll et autres
ca, us, in, dk (code pays fourni par la source)